Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Entdoctor Pharmaceutical is a specialized Chinese pharmaceutical enterprise dedicated to the research, development, and production of medications for ear, nose, and throat (ENT) health. Established in 2001 and headquartered in Nanchang, the company has built a comprehensive portfolio that includes nasal sprays, ear drops, and oral tablets for respiratory and ENT conditions. Their product line integrates modern chemical pharmacology with traditional Chinese medicine (TCM) to treat indications such as allergic rhinitis, sinusitis, and pharyngitis. The company operates advanced GMP-certified manufacturing facilities and is a recognized brand in the domestic Chinese market for specialized ENT care. Entdoctor continues to focus on expanding its reach within the OTC and hospital sectors through targeted therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Entdoctor Pharmaceutical.